NanoViricides Inc.
Market Cap
36M
Short interest (May 15)
3.3%
Net Short (Jun 03 ): 0.1%
Borrow Fee
4.43%
↑ 867.2%
Available Shares
400K
↑ 75.7%
Price Chart
Company Overview
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.